Manual of Clinical Nutrition

HIV Infection and AIDS

Manual of Clinical Nutrition Management III- 60 Copyright © 2013 Compass Group, Inc.

*The Academy of Nutrition and Dietetics has assigned grades, ranging from Grade I (good/strong) to Grade V (insufficient evidence), to
evidence and conclusion statements. The grading system is described in Section III: Clinical Nutrition Management A Reference Guide,
page III-1.

References

1. Position of the American Dietetic Association: nutrition intervention in human immunodeficiency virus infection. J Am Diet Assoc. 2010;
   110:1105-1119.


2. Joint United National Programme on HIV/AIDS. Report on the Global AIDS Epidemic. Executive Summary. Available at:
   http://data.unaids.org/pu/GlobalReport/2008/JC1511_GR08_ExecutiveSummary_en.pdf. Posted July 2008. Accessed October 1, 2010.


3. Centers for Disease Control and Prevention. HIV/AIDS data through December 2006. HIV/AIDS Surveillance Supplemental Report. 2009;14
   (No. 1). Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2009supp_vol14no1/pdf/HIVAIDS_SSR_Vol14_No1.pdf.
   Accessed July 23, 2009.


4. Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janseen RS. Estimation of HIV
   incidence in the United States. JAMA. 2008;300:520-529.


5. Centers for Disease Control and Prevention. CDC HIV/AIDS Facts: New Estimates of U.S. HIV Prevalence, 2006. Available at:
   http://www.cdc.gov/hiv/topics/surveillance/resources/factsheets/pdf/prevalence.pdf. Posted October 2008. Accessed July 23, 2009.


6. Centers for Disease Control and Prevention. 1993 revised HIV classification and expanded AIDS surveillance definition for AIDS among
   adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:1-19.


7. Cohen PT, Sande MA, Volberding PA, eds. The AIDS Knowledge Base: A Textbook on HIV Disease From the University of California, San
   Francisco, and the San Francisco General Hospital. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999. Available at:
   hivinsite.ucsf.edu. [University of California, San Francisco website]. Accessed March 30, 2005.


8. World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of
   HIV-Related Disease in Adults and Children. World Health Organization; 2007. Available at:
   http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf. Accessed October 28, 2010.


9. HIV/AIDS. In: Nutrition Care Manual. Updated annually. Academy of Nutrition and Dietetics. Available at:
   http://www.nutritioncaremanual.org. Accessed November 1, 2010.


10. Mangili A, Murman DH, Zampini AM, Wanke CA. Nutrition and HIV infection: review of weight loss and wasting in the era of highly
    active antiretroviral therapy from the nutrition for healthy living cohort. Clin Infect Dis. 2006;42:836-842.


11. Lo J, You SM, Wei J, Canavan B, Grinspoon S. Relationship of peak growth hormone to cardiovascular parameters, waist
    circumference, lipids and glucose in HIV-infected patients and healthy adults. Clin Endocrinol (Oxf). 2009;71:815-822.


12. Slama L, LeCamus C, Serfaty L, Pialoux G, Capeau J, Gharakhanian S. Metabolic disorders and chronic viral disease: the case of HIV
    and HCV. Diabetes Metab. 2009;35:1-11.


13. Llibre JM, Flaco V, Tural C, Negredo E, Pineda JA, Munoz J, Ortega E, Videla S, Sirera G, Martinez E, Miralles C, Iribarren J, Galindo MJ,
    Domingo P, d’Arminio-Monforte A, Miro JM, Clotet B. The changing face of HIV/AIDS in treated patients. Curr HIV Res. 2009;7:365-
    377.


14. Faintuch J, Soeters PB, Osmo HG. Nutritional and metabolic abnormalities in pre-AIDS HIV infection. Nutrition. 2006;22:68 3 - 690.


15. Kruzich LA, Marquis GS, Carriquiry AL, Wilson CM, Stephensen CB. US youths in the early stages of HIV disease have low intakes of
    some micronutrients for optimal immune function. J Am Diet Assoc. 2004;104:1095-1101.


16. Butensky E, Harmatz P, Lee M, Kennedy C, Petru A, Wara D, Miaskowski C. Altered iron metabolism in children with human
    immunodeficiency virus disease. Pediatr Hematol Oncol. 2009;26:69-84.


17. Schaible UE, Kaufmann SH. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med. 2007 May;4:e115.


18. Srasuebkul P, Lim PL, Lee MP, Kumarasamy N, Zhou J, Sirisanthana T, Li PC, Kamarulzaman A, Oka S, Phanuphak P, Vonthanak S,
    Merati TP, Chen YM, Sung-kanuparph S, Tau G, Zhang F, Lee CK, Ditangeo R, Pujari S, Choi JY, Smith J, Law MG. Short-term clinical
    disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV
    observational database. Clin Infect Dis. 2009;48:940-950.


19. Siddiqui J, Phillips AL, Freedland ES, Sklar AR, Darkow T, Harley CR. Prevalence and cost of HIV-associated weight loss in a
    managed care population. Curr Med Res Opin. 2009;25:1307-1317.


20. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS.
    Am J Clin Nutr. 1989;50:444-447.


21. HIV/AIDS Evidence Based Nutrition Practice Guidelines. Academy of Nutrition and Dietetics Evidence Analysis Library. Academy of
    Nutrition and Dietetics; December 2010. Available at: http://www.andevidencelibrary.com/topic.cfm?cat=4248. Accessed February 7,
    2013.


22. 13th annual HIV drug guide. Positively Aware. March/April 2009;20:28-55. Available at:
    positivelyaware.com/2009/09_02/09_02.pdf. Accessed April 21, 2009.


23. Fichtenbaum CJ. Metabolic abnormalities associated with HIV infection and antiretroviral therapy. Curr Infect Dis Rep. 2009;11:84-
    92.


24. Visnegarwala F, Shlay JC, Barry V, Gibert CL, Xiang Y, Wang J, Kotler D, Raghavan S, El-Sadar WM; for Terry Beirn Community
    Programs for Clinical Research on AIDS (CPCRA). Effects of HIV infection on body composition changes among men of different
    racial/ethnic orgins. HIV Clin Trial. 2007;8:145-154.


25. Lundgren JD, Battegay M, Behrens G, De Wit S, Guaraldi G, Katlama C, Martinez E, Nair D, Powderly WG, Reiss P, Sutinen J, Vigano A;
    EACS Executive Committee. European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic
    diseases in HIV. HIV Med. 2008;9:72-81.


26. Lagathu C, Kim M, Maachi M, Vigouroux C, Cervera P, Capeau J, Caron M, Bastard JP. HIV antiretroviral treatment alters adipokine
    expression and insulin sensitivity of adipose tissue in vitro and in vivo. Biochimie. 2005;87:65-71.


27. Diehl LA, Fabris BA, Barbosa DS, De Faria EC, Wiechmann SL, Carrilho AJ. Metformin increases HDL3-cholesterol and decreases
    subcutaneous truncal fat in nondiabetic patients with HIV-associated lipodystrophy. AIDS Patient Care STDS. 2008;22:779-786.


28. Schindler K, Rieger A, Tura A, Gmeinhardt B, Touzeau-Romer V, Haider D, Pacini G, Ludvik B. The effect of rosiglitazone on insulin
    sensitivity, beta cell function, bone mineral density, and body composition in HIV-positive patients on highly-active antiretroviral therapy
    (HAART). Horm Metab Res. 2009;41:573-579.


29. Mulligan K, Yang Y, Wininger DA, Koletar SL, Parker RA, Alston-Smith BL, Schouten JT, Fielding RA, Basar MT, Grinspoon S. Effects of
    Metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio. AIDS. 2007;21:47-57.


30. Rawat R, Stoltzfus RJ, Ntozini R, Mutasa K, Iliff PJ, Humphrey JH. Influence of inflammation as measured by alpha- 1 - acid glycoprotein on
    iron status indicators among HIV-positive postpartum Zimbabwean women. Eur J Clin Nutr. 2009;63:787-793.